Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia (Q83967551)
Jump to navigation
Jump to search
scientific article published on 26 April 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia |
scientific article published on 26 April 2011 |
Statements
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia (English)
Simona Lapusan
Xavier Thomas
Anne Vekhoff
Ruoping Tang
Rodica Morariu-Zamfir
John M Lambert
Marie-Laure Ozoux
Philippe Poncelet
Ollivier Legrand
Daniel J DeAngelo
Francis J Giles
Jean-Pierre Marie
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference